Discovery of ANO1 Inhibitors based on Machine learning and molecule docking simulation approaches.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published Date:

Abstract

Calcium-activated chloride channels (CaCCs) are chloride channels that are regulated according to intracellular calcium ion concentrations. The channel protein ANO1 is widely present in cells and is involved in physiological activities including cellular secretion, signaling, cell proliferation and vasoconstriction and diastole. In this study, the ANO1 inhibitors were investigated with machine learning and molecular simulation. Two-dimensional structure-activity relationship (2D-SAR) and three-dimensional quantitative structure-activity relationship (3D-QSAR) models were developed for the qualitative and quantitative prediction of ANO1 inhibitors. The results showed that the prediction accuracies of the model were 85.9% and 87.8% for the training and test sets, respectively, and 85.9% and 87.8% for the rotating forest (RF) in the 2D-SAR model. The CoMFA and CoMSIA methods were then used for 3D QSAR modeling of ANO1 inhibitors, respectively. The q coefficients for model cross-validation were all greater than 0.5, implying that we were able to obtain a stable model for drug activity prediction. Molecular docking was further used to simulate the interactions between the five most promising compounds predicted by the model and the ANO1 protein. The total score for the docking results between all five compounds and the target protein was greater than 6, indicating that they interacted strongly in the form of hydrogen bonds. Finally, simulations of amino acid mutations around the docking cavity of the target proteins showed that each molecule had two or more sites of reduced affinity following a single mutation, indicating outstanding specificity of the screened drug molecules and their protein ligands.

Authors

  • Junjie Zhong
    Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Ontario M5S3G8, Canada. sinton@mie.utoronto.ca.
  • Wendi Xuan
    School of life Science, Shanghai University, 99 Shangda Road,200444, China. Electronic address: wendy1221@shu.edu.cn.
  • Sheng Lu
    Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, PR China. Electronic address: lusheng@vip.126.com.
  • Shihao Cui
    School of life Science, Shanghai University, 99 Shangda Road,200444, China. Electronic address: 18csh@shu.edu.cn.
  • Yuhang Zhou
    Cardeza Foundation for Hematologic Research, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States.
  • Mengting Tang
    School of life Science, Shanghai University, 99 Shangda Road,200444, China. Electronic address: TMTtang@shu.edu.cn.
  • Xiaosheng Qu
    National Engineering laboratory of Southwest Endangered Medicinal Resources Development, Guangxi Botanical Garden of Medicinal Plants, China. Electronic address: quxs@gxyyzwy.com.
  • Wencong Lu
    Department of Chemistry, College of Sciences, Shanghai University, Shanghai 200444, China.
  • Haizhong Huo
    Department of General Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
  • Chi Zhang
    Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Ning Zhang
    Institute of Nuclear Agricultural Sciences, Zhejiang University, Hangzhou, 310058, China.
  • Bing Niu
    College of Life Science, Shanghai University, 99 Shang-Da Road, Shanghai 200444, China.